{
    "SPADE_N_13974": {
        "Clinical Information": [],
        "Patent Information": [],
        "Sequence Information": {
            "SPADE ID": "SPADE_N_13974",
            "Peptide Name": "GRR (Gly-rich region, Synthetic AMPs, N-terminal fragment of SpCrus2, UCLL1)",
            "Source": "Sequence truncation, Crustaceans, animal-derived, natural derivative",
            "Family": "Not found",
            "Gene": "Not found",
            "Sequence": "DDTRGGFHGGGFGRPGRPGRPGSGILDTIVDGLTGSIHGGQGGIHGGIHGGGHGGHGGVVHGRQ",
            "Sequence Length": 64,
            "UniProt Entry": "Ref",
            "Protein Existence": "Not found",
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-"
            ],
            "Target Organism": "Not found",
            "Hemolytic Activity": "Not found",
            "Cytotoxicity": "Not found",
            "Binding Target": "Not found",
            "Linear/Cyclic": "Not found",
            "N-terminal Modification": "Not found",
            "C-terminal Modification": "Not found",
            "Stereochemistry": "Not found",
            "Structure Description": "Not found",
            "Formula": "Not found",
            "Mass": 6111.52,
            "PI": 9.44,
            "Hydrophobicity": -0.57,
            "Half Life": "Not found",
            "Function": "Not found",
            "Literature": [
                {
                    "Author": "Wang H, Zhang JX, Wang Y, Fang WH, Wang Y, Zhou JF, Zhao S, Li XC. 2018",
                    "Reference": "Dev Comp Immunol. 2018 Jul;84:1-13. doi: 10.1016/j.dci.2018.01.021.PubMed",
                    "Title": "Newly identified type II crustin (SpCrus2) in Scylla paramamosain contains a distinct cysteine distribution pattern exhibiting broad antimicrobial activity."
                }
            ],
            "Frequent Amino Acids": "GHI",
            "Absent Amino Acids": "ACEKMNOUWY",
            "Basic Residues": 12,
            "Acidic Residues": 4,
            "Hydrophobic Residues": 15,
            "Polar Residues": 22,
            "Positive Residues": 12,
            "Negative Residues": 4,
            "Net Charge": 8,
            "Comments": "Sequence analysis: APD analysis reveals this sequence is most similar (43.54%) toSpCrus2G: 41%.Activity: Active against Gram+ B. subtilis (MIC 5.6-11.2 uM), B. megaterium (MIC 5.6-11.2 uM), Gram- V.  alginolyticus (MIC 2.8-5.6 uM), V. parahemolyticus (MIC 2.8-5.6 uM), V. harveyi (MIC 2.8-5.6 uM), E. coli (MIC 5.6-11.2 uM).Recombinant production:bacteria:Escherichia coli: expressed and prufied.",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_18646",
                    "Similarity": 1.0,
                    "Sequence": "DDTRGGFHGGGFGRPGRPGRPGSGILDTIVDGLTGSIHGGQGGIHGGIHGGGHGGHGGVVHGRQCGVNVPTHITTGCKLFTRNLYGQYVCDRNQKPAFRCPPLRAECPLATRFGPPIQCTLDTDCPGISDKCCCDACLDHPVCKPSA"
                },
                {
                    "SPADE_ID": "SPADE_N_08842",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "GGHGGHGGHGGHGGHGGH"
                },
                {
                    "SPADE_ID": "SPADE_N_14610",
                    "Similarity": 0.8333333333333334,
                    "Sequence": "GGHGGHGGHGGH"
                }
            ]
        }
    }
}